NRX Pharmaceuticals (NRXP) Long-Term Debt Repayments (2017 - 2024)
NRX Pharmaceuticals' Long-Term Debt Repayments was $3.05 million in Q4 2024, up 279.4% from $804,000 a year earlier and up 15.4% from the prior quarter.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) Long-Term Debt Repayments (2017 - 2024) Analysis & Trends
For FY2024, Long-Term Debt Repayments at NRX Pharmaceuticals came in at $7.85 million, up 153.9% from FY2023.
- Long-Term Debt Repayments shows a five-year compound annual growth rate of 160.9% (FY2019 to FY2024).
- In earlier years, Long-Term Debt Repayments was $3.09 million in FY2023 and $35,000 in FY2020 (-46.2%).
- The Q4 2024 figure marks the highest quarterly Long-Term Debt Repayments in data going back to Q1 2018.
- Per Business Quant data, NRXP's Long-Term Debt Repayments in the three quarters before Q4 2024 was $2.64 million (Q3 2024), $1,000 (Q2 2024) and $2.16 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | NRX Pharmaceuticals | 103.58 Mn | 55.17 Mn | 426,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 3.05 Mn |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 804,000.00 |
| Sep 30, 2023 | 2.20 Mn |
| Dec 31, 2020 | -214,461.00 |
| Sep 30, 2020 | 33,720.00 |
| Jun 30, 2020 | 23,221.00 |
| Mar 31, 2020 | 192,520.00 |
| Dec 31, 2019 | -854,147.00 |
| Sep 30, 2019 | 164,147.00 |
| Mar 31, 2019 | 755,000.00 |
| Dec 31, 2017 | 147,625.00 |
API Access
NRX Pharmaceuticals Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=NRXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "NRXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=NRXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();